IMMIX BIOPHARMA, INC. (IMMX) Net income 2021–2026
IMMIX BIOPHARMA, INC. (IMMX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$29.4MFY2026 · since FY2021: -$1.1M → -$29.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$29.4M | -36.0% |
| FY2025 | -$21.6M | -40.1% |
| FY2024 | -$15.4M | -87.4% |
| FY2023 | -$8.2M | +66.2% |
| FY2022 | -$24.4M | -2024.3% |
| FY2021 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice